MCF-7乳腺癌细胞中Myc对雌激素和磷脂酶D的应答性稳定作用。
Myc stabilization in response to estrogen and phospholipase D in MCF-7 breast cancer cells.
作者信息
Rodrik Vanessa, Gomes Evan, Hui Li, Rockwell Patricia, Foster David A
机构信息
Department of Biological Sciences, Hunter College of The City University of New York, 695 Park Avenue, New York, NY 10021, USA.
出版信息
FEBS Lett. 2006 Oct 16;580(24):5647-52. doi: 10.1016/j.febslet.2006.09.013. Epub 2006 Sep 18.
Abstract
Estrogen, which has been strongly implicated in breast cancer, suppresses apoptosis in estrogen receptor (ER) positive MCF-7 breast cancer cells. Phospholipase D (PLD), which is commonly elevated in ER negative breast cancer cells, also suppresses apoptosis. Survival signals generated by both estrogen and PLD are dependent upon elevated Myc expression. We report here that estrogen- and PLD-induced increases in Myc expression are due to reduced turnover of Myc protein. Estrogen and PLD suppressed phosphorylation of Myc at Thr58--a site that targets Myc for degradation by the proteasome. The data provide a mechanism for elevated Myc expression in hormone-dependent and hormone-independent breast cancer.
摘要
雌激素与乳腺癌密切相关，它可抑制雌激素受体（ER）阳性的MCF-7乳腺癌细胞的凋亡。磷脂酶D（PLD）在ER阴性乳腺癌细胞中通常升高，它也可抑制细胞凋亡。雌激素和PLD产生的存活信号均依赖于Myc表达的升高。我们在此报告，雌激素和PLD诱导的Myc表达增加是由于Myc蛋白周转减少所致。雌激素和PLD抑制了Myc在苏氨酸58位点的磷酸化，该位点是蛋白酶体将Myc降解的靶点。这些数据为激素依赖性和激素非依赖性乳腺癌中Myc表达升高提供了一种机制。
相似文献
1
Myc stabilization in response to estrogen and phospholipase D in MCF-7 breast cancer cells.
FEBS Lett. 2006 Oct 16;580(24):5647-52. doi: 10.1016/j.febslet.2006.09.013. Epub 2006 Sep 18.
2
Survival signals generated by estrogen and phospholipase D in MCF-7 breast cancer cells are dependent on Myc.
Mol Cell Biol. 2005 Sep;25(17):7917-25. doi: 10.1128/MCB.25.17.7917-7925.2005.
3
Estrogen and Myc negatively regulate expression of the EphA2 tyrosine kinase.
J Cell Biochem. 2002;85(4):714-20. doi: 10.1002/jcb.10186.
4
Modulation by phenylacetate of early estrogen-mediated events in MCF-7 breast cancer cells.
Cancer Chemother Pharmacol. 2007 Feb;59(2):217-25. doi: 10.1007/s00280-006-0260-3.
5
c-Myc overexpression and endocrine resistance in breast cancer.
J Steroid Biochem Mol Biol. 2006 Dec;102(1-5):147-55. doi: 10.1016/j.jsbmb.2006.09.028. Epub 2006 Oct 18.
6
Estrogen-dependent and independent activation of the P1 promoter of the p53 gene in transiently transfected breast cancer cells.
Oncogene. 1999 Jan 28;18(4):1067-72. doi: 10.1038/sj.onc.1202398.
7
Combined histone deacetylase inhibition and tamoxifen induces apoptosis in tamoxifen-resistant breast cancer models, by reversing Bcl-2 overexpression.
Breast Cancer Res. 2015 Feb 25;17(1):26. doi: 10.1186/s13058-015-0533-z.
8
Alternative phospholipase D/mTOR survival signal in human breast cancer cells.
Oncogene. 2005 Jan 20;24(4):672-9. doi: 10.1038/sj.onc.1208099.
9
Phospholipase D confers rapamycin resistance in human breast cancer cells.
Oncogene. 2003 Jun 19;22(25):3937-42. doi: 10.1038/sj.onc.1206565.
10
SRC Increases mRNA Expression in Estrogen Receptor-Positive Breast Cancer via mRNA Stabilization and Inhibition of p53 Function.
Mol Cell Biol. 2018 Feb 27;38(6). doi: 10.1128/MCB.00463-17. Print 2018 Mar 15.
引用本文的文献
1
Characterising the Response of Human Breast Cancer Cells to Polyamine Modulation.
Biomolecules. 2021 May 17;11(5):743. doi: 10.3390/biom11050743.
2
Carbonic Anhydrase XII Expression Is Modulated during Epithelial Mesenchymal Transition and Regulated through Protein Kinase C Signaling.
Int J Mol Sci. 2020 Jan 22;21(3):715. doi: 10.3390/ijms21030715.
3
Expression of p27 and c-Myc by immunohistochemistry in breast ductal cancers in African American women.
Ann Diagn Pathol. 2018 Jun;34:170-174. doi: 10.1016/j.anndiagpath.2018.03.013. Epub 2018 Apr 5.
4
Elevated phospholipase D activity in androgen-insensitive prostate cancer cells promotes both survival and metastatic phenotypes.
Cancer Lett. 2018 Jun 1;423:28-35. doi: 10.1016/j.canlet.2018.03.006. Epub 2018 Mar 8.
5
A Repertoire of MicroRNAs Regulates Cancer Cell Starvation by Targeting Phospholipase D in a Feedback Loop That Operates Maximally in Cancer Cells.
Mol Cell Biol. 2016 Jan 19;36(7):1078-89. doi: 10.1128/MCB.00711-15.
6
Phosphatidic acid and lipid-sensing by mTOR.
Trends Endocrinol Metab. 2013 Jun;24(6):272-8. doi: 10.1016/j.tem.2013.02.003. Epub 2013 Mar 16.
7
Paxillin phosphorylation and complexing with Erk and FAK are regulated by PLD activity in MDA-MB-231 cells.
Cell Signal. 2012 Aug;24(8):1531-40. doi: 10.1016/j.cellsig.2012.03.015. Epub 2012 Mar 28.
8
MYC and Breast Cancer.
Genes Cancer. 2010 Jun;1(6):629-40. doi: 10.1177/1947601910378691.
9
The exquisite regulation of PLD2 by a wealth of interacting proteins: S6K, Grb2, Sos, WASp and Rac2 (and a surprise discovery: PLD2 is a GEF).
Cell Signal. 2011 Dec;23(12):1885-95. doi: 10.1016/j.cellsig.2011.06.017. Epub 2011 Jun 29.
10
A p53-independent role of Mdm2 in estrogen-mediated activation of breast cancer cell proliferation.
Breast Cancer Res. 2011 Jan 11;13(1):R3. doi: 10.1186/bcr2804.
本文引用的文献
1
Phospholipase D couples survival and migration signals in stress response of human cancer cells.
J Biol Chem. 2006 Jun 9;281(23):15862-8. doi: 10.1074/jbc.M600660200. Epub 2006 Apr 4.
2
mTOR-dependent suppression of protein phosphatase 2A is critical for phospholipase D survival signals in human breast cancer cells.
J Biol Chem. 2005 Oct 28;280(43):35829-35. doi: 10.1074/jbc.M504192200. Epub 2005 Aug 18.
3
Survival signals generated by estrogen and phospholipase D in MCF-7 breast cancer cells are dependent on Myc.
Mol Cell Biol. 2005 Sep;25(17):7917-25. doi: 10.1128/MCB.25.17.7917-7925.2005.
4
Transcriptional regulation and transformation by Myc proteins.
Nat Rev Mol Cell Biol. 2005 Aug;6(8):635-45. doi: 10.1038/nrm1703.
5
Alternative phospholipase D/mTOR survival signal in human breast cancer cells.
Oncogene. 2005 Jan 20;24(4):672-9. doi: 10.1038/sj.onc.1208099.
6
The life cycle of C-myc: from synthesis to degradation.
Cell Cycle. 2004 Sep;3(9):1133-7. Epub 2004 Sep 5.
7
Targeting mTOR-mediated survival signals in anticancer therapeutic strategies.
Expert Rev Anticancer Ther. 2004 Aug;4(4):691-701. doi: 10.1586/14737140.4.4.691.
8
Estradiol abrogates apoptosis in breast cancer cells through inactivation of BAD: Ras-dependent nongenomic pathways requiring signaling through ERK and Akt.
Mol Biol Cell. 2004 Jul;15(7):3266-84. doi: 10.1091/mbc.e03-11-0823. Epub 2004 Apr 30.
9
A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells.
Nat Cell Biol. 2004 Apr;6(4):308-18. doi: 10.1038/ncb1110. Epub 2004 Mar 14.
10
Estradiol inhibits GSK3 and regulates interaction of estrogen receptors, GSK3, and beta-catenin in the hippocampus.
Mol Cell Neurosci. 2004 Mar;25(3):363-73. doi: 10.1016/j.mcn.2003.10.008.
Zotero 插件